India Pharma Outlook Team | Monday, 04 September 2023
LISSUN, one of India’s largest mental health platforms, has raised $1.3 million in a seed round led by Inflection Point Ventures (IPV) & Rainmatter Capital (Zerodha Group). The round also saw participation from existing investors IvyCap Ventures, WFC, Growx Ventures and a few other marquee angel investors. LISSUN has raised over $2.3 million to date in funding. The funds will be strategically allocated to enhance their technology and product offerings further, expand their services, and cultivate meaningful partnerships with healthcare institutions and other organizations.
Employing an innovative B2H2C (Business to Healthcare to Consumer) strategy, LISSUN collaborates with healthcare institutions to effectively address high-stress use cases across domains such as infertility, rehabilitation, nephrology, oncology, and more. Dr. Krishna Veer Singh, director & co-founder, LISSUN, says, "This investment signifies the validity of LISSUN's innovative approach in delivering scalable solutions within the mental health landscape. In a very short period of time, LISSUN has become one of the largest in the field and breaking the syndrome of 6As of Mental Health. We extend sincere gratitude to our investors for placing their trust in LISSUN. Their expertise and backing will empower us to enrich our offerings and extend our reach. With this injection of capital, we take a significant step forward in realizing our vision of solving mental health at scale, and everyone can access the care and support they rightfully deserve." Vinay Bansal, founder, Inflection Point Ventures says "In today's day and age, everyone has a high-stress life with multiple responsibilities. In our society, physical problems are attended to actively, and mental health is more often neglected and kept on the back burner.
We are still unaware of how to deal with mental issues as a stigma is attached to it. LISSUN's strategic acumen in creating scalable mental and emotional healthcare solutions are commendable. We are confident that their groundbreaking work will have a lasting impact, reshaping the approach to mental health.” Rainmatter Health backed by Zerodha founder Nithin Kamath made its inaugural investment in the mental health industry with LISSUN.
Tarun Gupta, director & co-founder, LISSUN, also added his perspective, saying, "Our journey with LISSUN has been driven by a shared commitment to redefining mental healthcare. We are a product-first company and build our products to deliver mental health effectively, seamlessly, and affordably. This investment will further our product & technology and extend our outreach, making quality & affordable mental health solutions accessible to a broader audience."